Perkembangan Vaksin COVID-19 Produksi Dalam Negeri
Pengembangan vaksin COVID-19 produksi dalam negeri melalui kerja sama dengan BUMN maupun perusahaan swasta terus berjalan, dan diharapkan dapat diedarkan dan digunakan pada 2022.
| ABX | ||
| 3,524.549 | ||
| 203.9780 | 0.0614% | |
| BISNIS-27 | ||
| 570.205 | ||
| 4.9260 | 0.0087% | |
| DBX | ||
| 4,384.033 | ||
| 3.9340 | 0.0009% | |
| ECONOMIC30 | ||
| 121.030 | ||
| 1.4420 | 0.0121% | |
| ESGQKEHATI | ||
| 130.550 | ||
| 1.3330 | 0.0103% | |
| ESGSKEHATI | ||
| 131.204 | ||
| 1.2470 | 0.0096% | |
| I-GRADE | ||
| 234.006 | ||
| 3.3610 | 0.0146% | |
| AUDRP | ||
| 11,312.280 | ||
| 6.0600 | 0.0536% | |
| EURRP | ||
| 19,607.480 | ||
| 11.4700 | 0.0585% | |
| JPYRP | ||
| 106.739 | ||
| 0.3348 | 0.3146% | |
| SINRP | ||
| 13,110.730 | ||
| 9.2100 | 0.0703% | |
| USDRP | ||
| 16,884.000 | ||
| 4.0000 | 0.0237% | |
